As of Nov 27
| +0.13 / +0.72%|
The 8 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 19.00. The median estimate represents a +42.70% increase from the last price of 18.22.
The current consensus among 8 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.